Rest easy with intravenous iron for dialysis patients?

Clinical Journal of the American Society of Nephrology

Volumn 13, Issue 3, 2018, Pages 363-365

  Li, Xiaojuan ^a   Kshirsagar, Abhijit V ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Cation Transport Proteins; Hematinics; Hepcidins; Intestinal Absorption; Iron; Iron Metabolism Disorders; Metal transporting protein 1; Nephrology; Renal dialysis

Indexed keywords

ANTIANEMIC AGENT; IRON; TRANSFERRIN;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMMUNITY CARE; CUMULATIVE SCALE; DIALYSIS; DRUG MEGADOSE; EDITORIAL; FREQUENCY ANALYSIS; GENETIC HETEROGENEITY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LONG TERM EXPOSURE; LOW DRUG DOSE; MORTALITY; NEPHROLOGY; PUBLICATION; QUALITY OF LIFE ASSESSMENT;

HUMANS; IRON; RENAL DIALYSIS;

EID: 85043318920     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00930118     Document Type: Editorial

References (10)

1. Sargent JA, Acchiardo SR: Iron requirements in hemodialysis. Blood Purif 22: 112–123, 2004
2. Andrews NC: Forging a field: The golden age of iron biology. Blood 112: 219–230, 2008
3. Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM; Conference Participants: Iron management in chronic kidney disease: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference. Kidney Int 89: 28–39, 2016
4. Hougen I, Collister D, Bourrier M, Ferguson T, Hochheim L, Komenda P, Rigatto C, Tangri N: Safety of intravenous iron in dialysis: A systematic review and meta-analysis. Clin J Am Soc Nephrol 13: 457–467, 2018
5. Brookhart MA, Freburger JK, Ellis AR, Winkelmayer WC, Wang L, Kshirsagar AV: Comparative short-term safety of sodium ferric gluconate versus iron sucrose in hemodialysis patients. Am J Kidney Dis 67: 119–127, 2016
6. Wang C, Graham DJ, Kane RC, Xie D, Wernecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu TC, Limb S, Worrall C, Kelman JA, Reichman ME: Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 314: 2062–2068, 2015
7. Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309: 1351–1355, 1994
8. Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA: The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med 126: 541.e1–541.e14, 2013
9. Freburger JK, Ellis AR, Wang L, Butler AM, Kshirsagar AV, Winkelmayer WC, Brookhart MA: Comparative effectiveness of iron and erythropoiesis-stimulating agent dosing on health-related quality of life in patients receiving hemodialysis. Am J Kidney Dis 67: 271–282, 2016
10. EU Clinical Trials Register: Proactive IV irOn therapy for HaemodiALysis patients (PIVOTAL): UK Multicentre Open-Label Randomised Controlled Trial of IV Iron Therapy in Incident Haemodialysis Patients. EudraCT 2013-002267-25. Available at: https://www.clinicaltrialsregister.eu/ctr-search/search? query=2013-002267-25. Accessed January 18, 2018